224 related articles for article (PubMed ID: 12906855)
1. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis.
Kurima K; Yang Y; Sorber K; Griffith AJ
Genomics; 2003 Sep; 82(3):300-8. PubMed ID: 12906855
[TBL] [Abstract][Full Text] [Related]
2. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins.
Keresztes G; Mutai H; Heller S
BMC Genomics; 2003 Jun; 4(1):24. PubMed ID: 12812529
[TBL] [Abstract][Full Text] [Related]
3. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.
Ramoz N; Rueda LA; Bouadjar B; Montoya LS; Orth G; Favre M
Nat Genet; 2002 Dec; 32(4):579-81. PubMed ID: 12426567
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
5. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
6. Epidermodysplasia verruciformis.
Burger B; Itin PH
Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
[TBL] [Abstract][Full Text] [Related]
7. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
8. Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease.
Imahorn E; Yüksel Z; Spoerri I; Gürel G; Imhof C; Saraçoğlu ZN; Koku Aksu AE; Rady PL; Tyring SK; Kempf W; Itin PH; Burger B
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1722-1726. PubMed ID: 28646613
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to the classification of epidermodysplasia verruciformis.
Huang S; Wu JH; Lewis DJ; Rady PL; Tyring SK
Int J Dermatol; 2018 Nov; 57(11):1344-1350. PubMed ID: 30156265
[TBL] [Abstract][Full Text] [Related]
10. TMC8 (EVER2) attenuates intracellular signaling by Zn2+ and Ca2+ and suppresses activation of Cl- currents.
Sirianant L; Ousingsawat J; Tian Y; Schreiber R; Kunzelmann K
Cell Signal; 2014 Dec; 26(12):2826-33. PubMed ID: 25220380
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
12. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma.
Tang W; Shi Z; Zhu Y; Shan Z; Jiang A; Wang A; Chen M; Bao Y; Ju G; Xu W; Wang J
Sci Rep; 2023 Jul; 13(1):11668. PubMed ID: 37468683
[TBL] [Abstract][Full Text] [Related]
14. Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the components.
Wu CJ; Li X; Sommers CL; Kurima K; Huh S; Bugos G; Dong L; Li W; Griffith AJ; Samelson LE
J Biol Chem; 2020 Nov; 295(47):16086-16099. PubMed ID: 32917726
[TBL] [Abstract][Full Text] [Related]
15. Epidermodysplasia verruciformis: report of two patients with autosomal dominant inheritance.
Miotto IZ; De Oliveira WRP
Dermatol Online J; 2021 Feb; 27(2):. PubMed ID: 33818984
[TBL] [Abstract][Full Text] [Related]
16. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
Esenboga S; Cagdas D; Alkanat NE; Güler Tezel G; Ersoy Evans S; Boztug K; Tezcan I
J Cosmet Dermatol; 2022 May; 21(5):2263-2267. PubMed ID: 34416085
[TBL] [Abstract][Full Text] [Related]
17. Epidermodysplasia Verruciformis: Genetic Heterogeneity and EVER1 and EVER2 Mutations Revealed by Genome-Wide Analysis.
Youssefian L; Vahidnezhad H; Mahmoudi H; Saeidian AH; Daneshpazhooh M; Kamyab Hesari K; Zeinali S; de Jong SJ; Orth G; Blanchet-Bardon C; Jouanguy E; Casanova JL; Uitto J
J Invest Dermatol; 2019 Jan; 139(1):241-244. PubMed ID: 30036492
[No Abstract] [Full Text] [Related]
18. Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations.
Zavattaro E; Azzimonti B; Mondini M; De Andrea M; Borgogna C; Dell'Oste V; Ferretti M; Nicola S; Cappellano G; Carando A; Leigheb G; Landolfo S; Dianzani U; Gariglio M
J Invest Dermatol; 2008 Mar; 128(3):732-5. PubMed ID: 17960179
[No Abstract] [Full Text] [Related]
19. The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.
Kalińska-Bienias A; Kowalewski C; Majewski S
Postepy Dermatol Alergol; 2016 Apr; 33(2):75-80. PubMed ID: 27279814
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.
Tate G; Suzuki T; Kishimoto K; Mitsuya T
J Hum Genet; 2004; 49(4):223-225. PubMed ID: 15042430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
